Related Experiment Video
Updated: Aug 24, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
[Epidemiology of tuberculosis in Abidjan, Ivory Coast: effects of HIV infection]
A Ngom1, E Aka-Danguy, N Koffi
1Service de Pneumologie, Centre Hospitalier Universitaire Cocody, Abidjan, Côte d'Ivoire.
Abstract:
Despite the rising morbidity and mortality of tuberculosis in patients with HIV infection, epidemiology of tuberculosis in the Ivory Coast remains under-documented. The aim of this retrospective study of 1638 cases of tuberculosis diagnosed in the Pneumology Department of the Abidjan University Hospital was to collect current epidemiological data. From 1986 to 1992, a total of 4631 patients were hospitalized at University Hospital-Abidjan. Clinical and serological tests to detect HIV infection were performed in 982 patients. During hospitalization all patients received the same treatment for tuberculosis (2RHZ/4RH). Tuberculosis accounted for 42 p. 100 of diagnoses with a prevalence of 234 patients per year and a rate of increase was 4.5 p. 100 per year. Most patients were between the ages of 20 and 40 years (59 p. 100) and of male sex (72 p. 100). Overall HIV seroprevalence was 44.5 p. 100 with a rate of increase of 4.4 p. 100 per year. The proportion of patients tested for HIV grew from 11 p. 100 to 98 p. 100 over the seven-year study period and infection rates were consistently higher in men than in women (sex ratio: 3 to 1). The mean percentage of extrapulmonary or disseminated tuberculosis was sharply higher in the last three years of study (from 23.5 p. 100 to 46 p. 100 after 1989). This study demonstrates that seroprevalence rate has increased and that this increase has been correlated with a rising incidence of lethal and extrapulmonary tuberculosis.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis